-
The Hong Kong University of Science and Technology (Guangzhou) (HKUST(GZ)) is located in Nansha, Guangzhou, the geometric center of the Guangdong-Hong Kong-Macao Greater Bay Area. It is perfectly
-
), Dongguan University of Technology, and the Dongguan Municipal Government. CityUHK (Dongguan) aims to develop into a world-class higher education institution, excelling in both research and education. The
-
genomic and immunological assays to identify drivers of disease (such as lupus or cancer) and then utilize immune engineering and synthetic biology to identify novel treatments. Our lab has been recently
-
culture, reproduction, or lentiviral technology. Candidates with less than one year of postdoctoral experience are preferred. Starting salary is US$66,300 per year plus benefits. Highly motivated and
-
impact on pricing and commercial initiatives. Act as the contact with technology, publishing, and customer services teams on topics and initiatives related to individual OA pricing and discounts
-
to disease immunology, ageing, biochemistry of extracellular matrix, fibroblast biology, model organisms of regeneration, computational biology, advanced tissue engineering, cell/gene/antibody therapy, as
-
inhibitors across the blood-brain barrier. Proof-of-principle in genetically engineered mouse models shows the power of this strategy. We now need dedicated scientists to help us realize the potential of gene
-
including working with pathogenic (BSL-2) strains. Experience with immunoassays including flow cytometry, ELISAs, and preferably multiplexing technology like Luminex or MSD. Including analysis and statistics
-
team environment that encourages innovation and excellence in project execution. Stakeholder Engagement: Collaborate with internal stakeholders across departments (e.g. Publishing, Sales, Technology
-
, Chemistry, or Engineering. At least one year of postdoctoral experience is required. Experience, Knowledge, Skills, and Abilities: Postdoctoral experience. Published in major journals within the scope of PRX